Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs OrderlyMeds

Eden
Graded #5

Higher grade

vs+17.19999999999999
OrderlyMeds
Graded #78

Lower grade

The verdict

Eden takes it — 89.6/100 to 72.4/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. High-disclosure, high-oversight compounded program with the cleanest verification signals.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOrderlyMeds +7
85
92
Dose & formulationEden +22
86
64
Clinical oversightEden +13
95
82
Labs & monitoringEden +39
92
53
FulfillmentEden +28
93
65
Contract termsEden +35
90
55
Eden · left barOrderlyMeds · right bar

The numbers

MetricEdenOrderlyMeds
WeighScore89.6/10072.4/100
GradeB+C
Scorecard rank#5#78
Semaglutide$239/mo$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)
Tirzepatide$349/mo$299/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Eden

Graded #5 · B+

Strengths

  • High verification confidence
  • Nationwide
  • Both molecules

Where it loses points

  • Premium pricing
  • Compounded only
OrderlyMeds

Graded #78 · C

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

Where it loses points

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard